Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Samrat Pharmachem Limited (SAMRATPH.BO)

Compare
340.85
+10.30
+(3.12%)
At close: April 17 at 3:58:19 PM GMT+5:30
Loading Chart for SAMRATPH.BO
  • Previous Close 330.55
  • Open 330.60
  • Bid 341.05 x --
  • Ask 344.95 x --
  • Day's Range 325.65 - 344.95
  • 52 Week Range 302.05 - 414.00
  • Volume 3,969
  • Avg. Volume 3,742
  • Market Cap (intraday) 1.053B
  • Beta (5Y Monthly) -0.03
  • PE Ratio (TTM) 11.83
  • EPS (TTM) 28.82
  • Earnings Date May 30, 2025
  • Forward Dividend & Yield 1.00 (0.30%)
  • Ex-Dividend Date Sep 19, 2024
  • 1y Target Est --

Samrat Pharmachem Limited engages in the manufacture and sale of pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodic acid, iodine, iodine monochloride, iodoquinol, lithium iodide, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate, potassium iodide, potassium metaper iodate, povidone iodine, selenium dioxide, sodium iodate, sodium iodide, sodium metaper iodate, sodium selenite, and tri methyl sulphoxonium iodide. The company serves agrochemical, animal feed, chemical, cosmetics, food, LCD screen, contrast media, pharmaceutical, screen printing, nylon textile, and tire cord manufacturing industries. It also exports its products to the United States, Europe, Africa, Asia, the Middle East, and internationally. Samrat Pharmachem Limited was incorporated in 1992 and is based in Mumbai, India.

www.samratpharmachem.com

32

Full Time Employees

March 31

Fiscal Year Ends

Chemicals

Industry

Recent News: SAMRATPH.BO

View More

Performance Overview: SAMRATPH.BO

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SAMRATPH.BO
10.92%
S&P BSE SENSEX (^BSESN)
0.53%

1-Year Return

SAMRATPH.BO
12.60%
S&P BSE SENSEX (^BSESN)
7.69%

3-Year Return

SAMRATPH.BO
12.60%
S&P BSE SENSEX (^BSESN)
34.65%

5-Year Return

SAMRATPH.BO
12.60%
S&P BSE SENSEX (^BSESN)
148.67%

Compare To: SAMRATPH.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SAMRATPH.BO

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    1.05B

  • Enterprise Value

    1.07B

  • Trailing P/E

    11.82

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.35

  • Price/Book (mrq)

    1.52

  • Enterprise Value/Revenue

    0.36

  • Enterprise Value/EBITDA

    8.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.99%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.97B

  • Net Income Avi to Common (ttm)

    89.07M

  • Diluted EPS (ttm)

    28.82

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    71.92M

  • Total Debt/Equity (mrq)

    13.16%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: SAMRATPH.BO

View More

Company Insights: SAMRATPH.BO

Research Reports: SAMRATPH.BO

View More

People Also Watch